Reports

2024 TCFD REPORT OVERVIEW
TCFD Report

2024 TCFD REPORT OVERVIEW

Samsung Biologics publishes a TCFD report annually for its stakeholders to transparently disclose the direction of its climate change response. This report is intended to boost the effectiveness of its response to climate change by transparently disclosing the company’s annual performance and activities and collecting various stakeholder opinions and reflecting them in business activities.

Reporting Period
This report covers the period from January 1, 2023 to December 31, 2023 in accordance with the CDP reporting standards and fiscal year criteria. Some pieces of information up to the date of publication in 2024 are included due to their significance. Data for the three years from 2021 to 2023 was provided for year-on-year comparison of quantitative data.
Reporting Standards
This report has been prepared in accordance with the TCFD recommendations by referring to the ISSB S2 climate disclosure standard.
Reporting Scope
Emissions were calculated across the entire scope of Samsung Biologics’ business, including its upstream and downstream processes, in accordance with CDP standards. The Scope 1, 2, and 3 data of Samsung Bioepis, a subsidiary of Samsung Biologics, was included in accordance with the 2023 consolidated standards. Both financial and non-financial information, including entire climate-related performance, has all been prepared in accordance with fiscal years pursuant to our disclosure system. Data related to energy use and GHG emissions have been prepared in accordance with third-party verification results.
Library

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION